Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare:

For permissions and non-commercial reprint enquiries, please visit to start a request.

For author reprints, please email
Information image
Average (ratings)
No ratings
Your rating
Open Access:

This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

This year’s final issue of Interventional Cardiology Review contains a superb section on the assessment and treatment of calcified coronary artery disease. Five articles commissioned by guest editor Nicolas Van Mieghem cover ‘all you need to know but were too scared to ask’ about this ever-relevant subject.

The rest of the issue is evenly split between structural and coronary papers offering, as usual I hope, interesting and useful updates on specific issues that interventional cardiologists are commonly faced with. The coronary section comprises excellent reviews of the contemporary management of cardiac arrest and of left main stem disease, as well as the promise of drug-coated balloons for the treatment of small vessel disease. In the structural section, there is an interesting review of sex and TAVI, as well as a timely review of current thinking regarding the ever-evolving subject of how to treat multi-valve disease. The brutal, but innovative, concept of bioprosthetic valve fracture completes the set.

Finally, I am delighted to welcome Nicolas Van Mieghem, Andrew Sharp and Joost Daemen to the editorial board. I know their enthusiasm and knowledge will enhance the journal and I am looking forward to working with them.